FDA OKs Therapy for Deadly Pediatric Immune Disorder

(MedPage Today) -- The FDA on Thursday granted accelerated approval to marnetegragene autotemcel (Kresladi) as the first gene therapy for treating kids with severe leukocyte adhesion deficiency type I (LAD-I), an ultra-rare inherited immune deficiency...
Source
MedPage Today
Opens original article in a new tab



